title: [Is the era from the end of warfarin?].
authors.affiliation: pdrstiefel@aol.com
authors.forename: Peter
authors.initials: P
authors.lastname: Stiefelhagen
mesh_terms: D000925:Anticoagulants / Q000627:therapeutic use*; D001562:Benzimidazoles / Q000627:therapeutic use*; D000069604:Dabigatran; D065427:Factor Xa Inhibitors; D006801:Humans; D009025:Morpholines / Q000627:therapeutic use; D010644:Phenprocoumon / Q000627:therapeutic use*; D000069552:Rivaroxaban; D013876:Thiophenes / Q000627:therapeutic use; D014812:Vitamin K / Q000037:antagonists & inhibitors*; D015091:beta-Alanine / Q000031:analogs & derivatives* / Q000627:therapeutic use
chemical_list: D000925:Anticoagulants; D001562:Benzimidazoles; D065427:Factor Xa Inhibitors; D009025:Morpholines; D013876:Thiophenes; D015091:beta-Alanine; D014812:Vitamin K; D000069552:Rivaroxaban; D000069604:Dabigatran; D010644:Phenprocoumon